Case Report
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jul 26, 2022; 10(21): 7467-7473
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7467
Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report
Ming-Hui Sun, Wei-Dong Yi, Ling Shen, Lu Zhou, Jian-Xun Lu
Ming-Hui Sun, Wei-Dong Yi, Ling Shen, Lu Zhou, Jian-Xun Lu, Department of Oncology, The First People's Hospital of Nanning, Nanning 530022, Guangxi Zhuang Autonomous Region, China
Author contributions: Sun MH was a major contributor in writing the manuscript; Lu JX and Yi WD analyzed and interpreted the patient data for transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma; Zhou L and Shen L presented information and contributed to editing and revision of the article; all authors approved submission of the manuscript.
Supported by the Self-funded Project of the Health Committee of Guangxi Zhuang Autonomous Region, No. z20190848.
Informed consent statement: Written consent to publish information was obtained from the patient.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jian-Xun Lu, MD, Assistant Professor, Department of Oncology, The First People's Hospital of Nanning, No. 89 Qixing Road, Nanning 530022, Guangxi Zhuang Autonomous Region, China. lujianxun1970@sina.com
Received: November 24, 2021
Peer-review started: November 24, 2021
First decision: April 13, 2022
Revised: April 28, 2022
Accepted: June 3, 2022
Article in press: June 3, 2022
Published online: July 26, 2022
Processing time: 229 Days and 4.5 Hours
Core Tip

Core Tip: Tumors of the lacrimal sac are extremely rare but are potentially devastating lesions that lack an effective remedy. We present a case of lacrimal sac squamous cell carcinoma that was treated with transcatheter arterial infusion chemotherapy and interventional embolization to provide a reference for the treatment of primary lacrimal sac tumors.